“We are pushing beyond what was thought possible to develop and deliver new RNA- and DNA-targeted therapies that will have a direct and meaningful impact on people living with serious diseases.”
Ionis Pharmaceuticals, Inc.
Biotechnology Research
Carlsbad, CA 112,301 followers
Building on our impossible firsts, we can change the course of human health.
Who We Are
We are over 1,400 people with a strong, distinct culture focused on helping people with intractable diseases. Ionis was founded in 1989 to create a new genetic medicines approach for human therapeutics known as “antisense.” We are a fully integrated commercial biotechnology company with multiple marketed medicines and a robust late-stage pipeline.
Learn MoreThe Ionis Impact
We invented the first breakthrough treatments for spinal muscular atrophy (SMA), a genetic form of amyotrophic lateral sclerosis (ALS) and familial chylomicronemia syndrome (FCS). In addition to advancing science and discovering medical breakthroughs that have redefined life for people with serious diseases, we work with a variety of patient advocacy groups to support patients and caregivers worldwide.
Our StoryOur Leadership
We are guided by world-class scientists and business leaders whose drive and passion to innovate is matched only by their commitment to deliver first-in-class and best-in-class medicines to the patients who need them.
Meet Our Leaders